ARCHIVES

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

This article is from The Cancer Letter archive.

Vol. 30 No. 26 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

ACCC Presentations On Care In Community

March 27, 1981

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

July 11, 2003

ACCC Comments On DRGs to Be Review By PROPAC

September 6, 1985

Prostate Cancer: NIH Pans To Ramp Up Prostate Cancer Research Funding

June 25, 1999

NCI Names Brawly Director of Office of Special Populations

June 21, 1996